Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Herzog

Katharina Herzog

Visiting research fellow

Herzog

Fibroblast-specific genome-scale modelling predicts an imbalance in amino acid metabolism in Refsum disease

Author

  • Agnieszka B. Wegrzyn
  • Katharina Herzog
  • Albert Gerding
  • Marcel Kwiatkowski
  • Justina C. Wolters
  • Amalia M. Dolga
  • Alida E.M. van Lint
  • Ronald J.A. Wanders
  • Hans R. Waterham
  • Barbara M. Bakker

Summary, in English

Refsum disease (RD) is an inborn error of metabolism that is characterised by a defect in peroxisomal α-oxidation of the branched-chain fatty acid phytanic acid. The disorder presents with late-onset progressive retinitis pigmentosa and polyneuropathy and can be diagnosed biochemically by elevated levels of phytanate in plasma and tissues of patients. To date, no cure exists for RD, but phytanate levels in patients can be reduced by plasmapheresis and a strict diet. In this study, we reconstructed a fibroblast-specific genome-scale model based on the recently published, FAD-curated model, based on Recon3D reconstruction. We used transcriptomics (available via GEO database with identifier GSE138379), metabolomics and proteomics (available via ProteomeXchange with identifier PXD015518) data, which we obtained from healthy controls and RD patient fibroblasts incubated with phytol, a precursor of phytanic acid. Our model correctly represents the metabolism of phytanate and displays fibroblast-specific metabolic functions. Using this model, we investigated the metabolic phenotype of RD at the genome scale, and we studied the effect of phytanate on cell metabolism. We identified 53 metabolites that were predicted to discriminate between healthy and RD patients, several of which with a link to amino acid metabolism. Ultimately, these insights in metabolic changes may provide leads for pathophysiology and therapy. Databases: Transcriptomics data are available via GEO database with identifier GSE138379, and proteomics data are available via ProteomeXchange with identifier PXD015518.

Department/s

  • Centre for Analysis and Synthesis

Publishing year

2020-12

Language

English

Pages

5096-5113

Publication/Series

The FEBS Journal

Volume

287

Issue

23

Document type

Journal article

Publisher

Wiley-Blackwell

Topic

  • Neurology

Keywords

  • amino acids
  • fibroblast
  • genome-scale modelling
  • metabolism
  • Refsum disease

Status

Published

ISBN/ISSN/Other

  • ISSN: 1742-464X